SignalXSignalX

GERN GERON CORP

8-K Current Report
Filed: February 25, 2026
Health Care
Pharmaceutical Preparations
GERON CORP Overview

GERON CORP (GERN) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 financial results disclosed via press release (Exhibit 99.1) dated Feb 25, 2026
  • • Actual figures — revenue, expenses, cash position — contained in Exhibit 99.1; review required for specific metrics
+1 more insights

Get deeper insights on GERON CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.